Optimum management of pediatric patients with fever and neutropenia (original) (raw)

• Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.Ann Intern Med 1966; 64(2): 328–340.
  PubMed CAS Google Scholar
• Schimpff S, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.N Engl J Med 1971; 284(19): 1061–1065.
  Article PubMed CAS Google Scholar
• Pizzo PA, Robichaud KJ, Gill FA_et al._ Duration of empiric antibiotic therapy in granulocytopenic patients with cancer.Am J Med 1979; 67(2): 194–200.
  Article PubMed CAS Google Scholar
• Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.Am JMed 1982; 72(1): 101–111.
  CAS Google Scholar
• Paganini HR, Sarkis CM, De Martino MG_et al._ Oral administration of cefixime to lower risk febrile neutropenic children with cancer.Cancer 2000; 88(12): 2848–2852.
  Article PubMed CAS Google Scholar
• Shenep JL, Flynn PM, Baker DK_et al._ Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.Clin Infect Dis 2001; 32(1): 36–43.
  Article PubMed CAS Google Scholar
• Mullen CA, Petropoulos D, Roberts WM_et al._ Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.Cancer 1999; 86(1): 126–134.
  Article PubMed CAS Google Scholar
• Petrilli AS, Dantas LS, Campos MC_et al._ Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.Med Pediatr Oncol 2000; 34(2): 87–91.
  Article PubMed CAS Google Scholar
• Paganini H, Rodriguez-Brieshcke T, Zubizarreta P_et al._ Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.Cancer 2001; 91(8): 1563–1567.
  Article PubMed CAS Google Scholar
• Paganini H, Gomez S, Ruvinsky S_et al._ Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.Cancer 2003; 97(7): 1775–1780.
  Article PubMed Google Scholar
• Indian Society of Medical & Pediatric Oncology. Indian Guidelines-Febrile Neutropenia. 2002.
• Uma A, Mehta A, Ayyagari A_et al._ Prevalance of a-lactamase producing strains among clinical isolates obtained from hospital in-patients across India and comparision of antibacterial susceptibility using disc diffusion method. Hospital Today 2004 IX(1).
• Mehndiratta PL, Vidhani S, Mathur MD. A study on Staphylococcus aureus strains submitted to a reference laboratory.Indian JMed Res 2001; 114: 90–94.
  CAS Google Scholar
• Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN).Lancet 1999; 353(9160): 1216–1221.
  Article Google Scholar
• Hughes WT, Armstrong D, Bodey GP_et al._ 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Clin Infect Dis 2002; 34(6): 730–751.
  Article PubMed Google Scholar
• Gaur AH, Giannini MA, Flynn PM_et al._ Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volume.Pediatr Infect Dis J 2003; 22(6): 545–552.
  Article PubMed Google Scholar
• Gaur AH, Flynn PM, Giannini MA_et al._ Difference in time to detection: a simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients.Clin Infect Dis 2003; 37(4): 469–475.
  Article PubMed Google Scholar
• Klastersky J, Paesmans M, Rubenstein EB_et al._ The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.J Clin Oncol 2000; 18(16): 3038–3051.
  PubMed CAS Google Scholar
• Santolaya ME, Alvarez AM, Aviles CL_et al._ Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.Clin Infect Dis 2002; 35(6): 678–683.
  Article PubMed CAS Google Scholar
• Klaassen RJ, Goodman TR, Pham B, Doyle JJ. Low-risk prediction rule for pediatric oncology patients presenting with fever and neutropenia.J Clin Oncol 2000; 18(5): 1012–1019.
  PubMed CAS Google Scholar
• Ammann RA, Hirt A, Luthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.Pediatr Infect Dis J 2004; 23(1): 61–67.
  Article PubMed Google Scholar
• Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.BMJ 2004; 328(7441): 668.
  Article PubMed CAS Google Scholar
• Del Favero A, Menichetti F, Martino P_et al._ A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.Clin Infect Dis 2001; 33(8): 1295–301.
  Article PubMed Google Scholar
• Gorschluter M, Hahn C, Fixson A_et al._ Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.Support Care Cancer 2003; 11(6): 362–370.
  PubMed CAS Google Scholar
• Winston DJ, Bartoni K, Bruckner DA_et al._ Randomized comparison of sulbactamJcefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.Clin Infect Dis 1998; 26(3): 576–583.
  PubMed CAS Google Scholar
• Jones RN, Rhomberg PR, Varnam DJ, Mathai D. A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multi-drug resistant Gram-negative bacilli including bacteraemic Salmonella spp.: initial studies for the MYSTIC programme in India.Int J Antimicrob Agents 2002; 20(6): 426–431.
  Article PubMed CAS Google Scholar
• Cometta A, Kern WV, De Bock R_et al._ Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.Clin Infect Dis 2003; 37(3): 382–389.
  Article PubMed CAS Google Scholar
• Santolaya ME, Villarroel M, Avendano LF, Cofre J. Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study.Clin Infect Dis 1997; 25(1): 92–97.
  PubMed CAS Google Scholar
• Clark OA, Lyman G, Castro AA_et al._ Colony stimulating factors for chemotherapy induced febrile neutropenia.Cochrane Database Syst Rev 2003; (3): CD003039.
• Bow EJ, Laverdiere M, Lussier N_et al._ Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.Cancer 2002; 94(12): 3230–3246.
  Article PubMed CAS Google Scholar